ResultsIQ

ResultsIQ › Latest results › Clean Science and Technology Limited

Clean Science and Technology Limited Q3 FY26 results deck summary

NSE: CLEAN · BSE: 543318

Results deck of 31 Jan 2026, summarised by AI from the filing.

Q3 FY2026 standalone revenue ₹185 cr (down 20% YoY) and PAT ₹52 cr (down 30% YoY); Hydroquinone and Catechol commercialized.

Key takeaways

  1. Q3 FY2026 revenue Standalone total revenue ₹185 cr (Q3 FY2025: ₹231 cr, -20%); consolidated ₹219 cr (Q3 FY2025: ₹240 cr, -9%).
  2. Q3 FY2026 PAT Standalone PAT ₹52 cr (Q3 FY2025: ₹74 cr, -30%); consolidated ₹46 cr (Q3 FY2025: ₹66 cr, -30%).
  3. Capex Incurred total capex of ~₹165 cr during 9M FY2026, primarily towards investment in Clean Fino Chem Ltd. (CFCL), wholly owned subsidiary of CSTL.
  4. Product commercialization Commercialized Hydroquinone and Catechol in Q3 FY26.
  5. Dividend Board approved interim dividend of ₹2 per share.

Original filing on BSE

Clean Science and Technology Limited Q1 FY27 results

As filed: Revenue ₹268 cr (+10% year on year), EBITDA ₹96.4 cr (−5% year on year), PAT ₹73.4 cr (+5% year on year), EBITDA margin 35.9% (−564 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹249 cr (−6% year on year), EBITDA ₹95.8 cr (−9% year on year), PAT ₹58.3 cr (−21% year on year), EBITDA margin 38.4% (−135 bps). Score 29 of 100, Below trend. Revenue and profit growth were well below the company's own trend; EBITDA growth was below it. EBITDA margin fell 135 bps year on year. Share price after the results: −5.8% in 29 days (Nifty 500: +1.0%).
  • Q3 FY26: Revenue ₹220 cr (−9% year on year), EBITDA ₹72.2 cr (−26% year on year), PAT ₹45.9 cr (−30% year on year), EBITDA margin 32.9% (−780 bps). Score 14 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 780 bps year on year. Revenue fell 10% from last quarter. Share price after the results: −8.1% in 30 days (Nifty 500: −1.1%).
  • Q2 FY26: Revenue ₹245 cr (+3% year on year), EBITDA ₹87.0 cr (−3% year on year), PAT ₹55.0 cr (−7% year on year), EBITDA margin 35.5% (−230 bps). Score 38 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 230 bps year on year. Profit fell 21% from last quarter. Share price after the results: −11.6% in 30 days (Nifty 500: +2.0%).
  • Q1 FY26: Revenue ₹243 cr (+8% year on year), EBITDA ₹101 cr (+6% year on year), PAT ₹70.0 cr (+6% year on year), EBITDA margin 41.6% (−85 bps). Score 52 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 85 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −18.3% in 28 days (Nifty 500: −3.2%).
  • Q4 FY25: Revenue ₹264 cr (+16% year on year), EBITDA ₹105 cr (+11% year on year), PAT ₹74.0 cr (+6% year on year), EBITDA margin 39.8% (−189 bps). Score 56 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 189 bps year on year. Share price after the results: +10.4% in 29 days (Nifty 500: +1.4%).
  • Q3 FY25: Revenue ₹241 cr (+24% year on year), EBITDA ₹98.0 cr (+14% year on year), PAT ₹66.0 cr (+5% year on year), EBITDA margin 40.7% (−344 bps). Score 59 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit growth was in line with it. EBITDA margin fell 344 bps year on year.
  • Q2 FY25: Revenue ₹238 cr (+31% year on year), EBITDA ₹90.0 cr (+22% year on year), PAT ₹59.0 cr (+13% year on year), EBITDA margin 37.8% (−307 bps). Score 60 of 100, In line with trend. EBITDA margin fell 307 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 11% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Clean Science and Technology Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.